Mpm Bioventures 2018 L.p. insider trades

Open-market stock purchases and sales by Mpm Bioventures 2018 L.p., Unknown at Entrada Therapeutics, Inc, from SEC Form 4 filings since Sep 21, 2020.

Track record: 0% of 2 scored buys are up 5% or more since purchase, averaging -42%.

Recent trades

DateStockTradeValue
Sep 9, 2026TRDA Entrada Therapeutics, IncSold$206K
Sep 8, 2026TRDA Entrada Therapeutics, IncSold$1.4M
Sep 4, 2026TRDA Entrada Therapeutics, IncSold$274K
Sep 3, 2026TRDA Entrada Therapeutics, IncSold$231K
Sep 2, 2026TRDA Entrada Therapeutics, IncSold$181K
Sep 1, 2026TRDA Entrada Therapeutics, IncSold$205K
Aug 26, 2026TRDA Entrada Therapeutics, IncSold$103K
Aug 25, 2026TRDA Entrada Therapeutics, IncSold$200K
Aug 24, 2026TRDA Entrada Therapeutics, IncSold$159K
Jan 12, 2026AKTS Aktis Oncology, IncBought (not open market)—
Jan 12, 2026AKTS Aktis Oncology, IncBought (not open market)—
Jan 12, 2026AKTS Aktis Oncology, IncBought (not open market)—
Jan 12, 2026AKTS Aktis Oncology, IncBought$20M
Jan 12, 2026AKTS Aktis Oncology, IncBought (not open market)—
Jan 12, 2026AKTS Aktis Oncology, IncBought (not open market)—
Jan 12, 2026AKTS Aktis Oncology, IncBought (not open market)—

Companies traded

  • TRDA Entrada Therapeutics, Inc: 1 buy, 11 sales, last Sep 9, 2026
  • AKTS Aktis Oncology, Inc: 1 buy, last Jan 12, 2026
  • ITOS iTeos Therapeutics, Inc: 73 sales, last May 13, 2025
  • DYN Dyne Therapeutics, Inc: other filings, last Sep 21, 2020

Get free alerts when Mpm Bioventures 2018 L.p. files a new trade →